Gilead Sciences
GILD
97,14 โฌ
Share price
0.41%
Change (1 day)
32.08%
Change (1 year)
Categories
Market capitalization of Gilead Sciences (GILD)
Market cap: โฌ120.52 Billion
As of September 2025 Gilead Sciences has a market cap of โฌ120.52 Billion. This makes Gilead Sciences the world's 134th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Gilead Sciences from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | โฌ120.52 B | 6.94% |
| 2024 | โฌ112.70 B | 23.43% |
| 2023 | โฌ91.31 B | -9.04% |
| 2022 | โฌ100.38 B | 24.85% |
| 2021 | โฌ80.39 B | 35.41% |
| 2020 | โฌ59.37 B | -19.15% |
| 2019 | โฌ73.43 B | 4.76% |
| 2018 | โฌ70.09 B | -10.13% |
| 2017 | โฌ77.99 B | -13.04% |
| 2016 | โฌ89.69 B | -31.85% |
| 2015 | โฌ131.60 B | 13.28% |
| 2014 | โฌ116.17 B | 39.23% |
| 2013 | โฌ83.44 B | 97.84% |
| 2012 | โฌ42.17 B | 78.16% |
| 2011 | โฌ23.67 B | 8.34% |
| 2010 | โฌ21.85 B | -19.59% |
| 2009 | โฌ27.17 B | -18.41% |
| 2008 | โฌ33.30 B | 13.79% |
| 2007 | โฌ29.26 B | 28.99% |
| 2006 | โฌ22.69 B | 11.22% |
| 2005 | โฌ20.40 B | 76.23% |
| 2004 | โฌ11.57 B | 17.28% |
| 2003 | โฌ9.87 B | 53.6% |
| 2002 | โฌ6.42 B | -10.52% |
| 2001 | โฌ7.18 B | 73.04% |
| 2000 | โฌ4.15 B | 75.01% |
| 1999 | โฌ2.37 B | 123.19% |
| 1998 | โฌ1.06 B | 9.73% |
| 1997 | โฌ0.96 B | 59.86% |
| 1996 | โฌ0.60 B |
End of Day market cap according to different sources
On Sep 20th, 2025 the market cap of Gilead Sciences was reported to be:
โฌ120.52 Billion
โฌ120.52 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | โฌ130.82 B | 8.54% | ๐บ๐ธ USA |
 Vertex Pharmaceuticals VRTX | โฌ83.63 B | -30.61% | ๐บ๐ธ USA |
 AbbVie ABBV | โฌ334.60 B | 177.62% | ๐บ๐ธ USA |
 Illumina ILMN | โฌ13.44 B | -88.84% | ๐บ๐ธ USA |
 Biogen BIIB | โฌ17.78 B | -85.24% | ๐บ๐ธ USA |
 Pfizer PFE | โฌ116.32 B | -3.49% | ๐บ๐ธ USA |
 Johnson & Johnson JNJ | โฌ361.27 B | 199.74% | ๐บ๐ธ USA |
 Eli Lilly LLY | โฌ573.95 B | 376.20% | ๐บ๐ธ USA |
 Merck MRK | โฌ173.34 B | 43.82% | ๐บ๐ธ USA |